Liu Yang

Future FinTech Group Inc.Alphamab Oncology - B

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 1 buy · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€428k

▼ Sales (0 ops.)

—

Latest filing published 23 Jun 2026 for Alphamab Oncology - B, €428k. Read the official filing

Filing timeline

BuySale

Liu Yang

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Liu Yang: trading record in brief

Liu Yang is a declared insider at 2 companies; the most frequent names are Alphamab Oncology - B and Future FinTech Group Inc. We count 2 filings; the first trade dates from 12 July 2021 and the latest from 4 June 2026.

No open-market sale appears; the market trades are 1 purchase worth €428k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. In 2026 alone, the filings show 1 purchase and no sales.

The latest filing, published on 23 June 2026, reports an open-market purchase of €428k in Alphamab Oncology - B. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.